跳至主要内容
临床试验/ITMCTR2100005166
ITMCTR2100005166尚未招募4 期

A prospective, single-arm, multi-center phase IV clinical research to evaluate the safety of Jinhua Qinggan Granules in the treatment of influenza

Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 A(—)
性别
All

入选标准

  • 1.Meet the influenza clinical diagnosis standard of Influenza Diagnosis and Treatment Plan (2020 Edition);
  • 2.The age range of patients is over 18 years old (inclusive);
  • 3.The course of disease was within 48 hours;
  • 4.Agree to participate in this study and sign a written informed consent form.

排除标准

  • 1. Severe or critically ill patients with influenza;
  • 2. Patients with abnormal liver function;
  • 3. Abnormal blood routine indexes;
  • 4. The patient has test data reflecting abnormal renal function;
  • 5. Pregnant and lactating patients;
  • 6. Combination of serious primary diseases of the heart, brain, lung, liver, kidney and blood system, such as viral hepatitis, hemophilia, mental illness, etc.;
  • 7. According to the judgment of the researcher, there are other diseases or conditions that reduce the possibility of enrollment or complicate enrollment, such as pregnancy, frequent changes in working environment, unstable living environment, etc., which are likely to cause loss to follow-up;
  • 8. Other investigators judge that there are patients who affect the safety of the drug.

研究者

发起方
Beijing Traditional Chinese Medicine Hospital Affiliated to Capital Medical University

相似试验

A prospective, single-arm, multi-center phase IV... | 临床试验